Vestal Point Capital, LP Uni Qure N.V. Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Vestal Point Capital, LP holds 3,025,000 shares of QURE stock, worth $36.6 Million. This represents 3.17% of its overall portfolio holdings.
Number of Shares
3,025,000
Previous 4,750,000
36.32%
Holding current value
$36.6 Million
Previous $23.4 Billion
128.13%
% of portfolio
3.17%
Previous 1.78%
Shares
4 transactions
Others Institutions Holding QURE
# of Institutions
171Shares Held
42.5MCall Options Held
2.61MPut Options Held
582K-
Eco R1 Capital, LLC San Francisco, CA3.4MShares$41.1 Million2.81% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$29.7 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$26.3 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$24 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$23.3 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $565M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...